tetradecanoylphorbol acetate has been researched along with Huntington Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nukina, N; Zemskov, EA | 1 |
Birdsall, M; Coles, R; Rubinsztein, DC; Wyttenbach, A | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Huntington Disease
Article | Year |
---|---|
Impaired degradation of PKCalpha by proteasome in a cellular model of Huntington's disease.
Topics: Animals; Cell Membrane; Cysteine Endopeptidases; Cytosol; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Humans; Huntington Disease; Mice; Multienzyme Complexes; Mutation; Neuroblastoma; Precipitin Tests; Proteasome Endopeptidase Complex; Protein Kinase C; Protein Kinase C-alpha; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Ubiquitin | 2003 |
12-O-tetradecanoyl-phorbol-13-acetate down-regulates the Huntingtin promoter at Sp1 sites.
Topics: Chromosome Mapping; Down-Regulation; Gene Expression Regulation; HeLa Cells; Humans; Huntingtin Protein; Huntington Disease; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Promoter Regions, Genetic; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Cells, Cultured | 2000 |